Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cochlear Norway AS
AS
Active
Org 999642993
Brynsveien 13, 0667
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2013 · 13 years old
8 employees
www.cochlear.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Cochlear Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
59M
44M
29M
15M
0M
2021: 30M
30M
2021
2022: 33M (+10% vs 2021)
33M
+10%
2022
2023: 47M (+42% vs 2022)
47M
+42%
2023
2024: 43M (-9% vs 2023)
43M
-9%
2024
2025: 42M (-2% vs 2024)
42M
-2%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
42 118
42 620
46 856
32 836
30 414
Staff expenses
−0
−0
−0
−0
−0
EBITDA
1 887
1 863
2 147
1 509
1 058
Depreciation & amort.
−1
−0
−2
−47
−68
EBIT
1 886
1 863
2 145
1 462
990
Net financials
89
129
26
31
6
Profit before tax
1 975
1 993
2 171
1 492
996
Tax
−0
−0
−0
−0
328
Net profit
1 522
1 554
1 693
1 164
668
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
15 749
14 881
18 362
18 274
19 926
Equity
7 187
5 666
7 611
5 918
4 754
Long-term debt
0
0
0
0
0
Short-term debt
8 562
9 215
10 750
12 355
15 172
Total debt
8 562
9 215
10 750
12 355
15 172
Financial ratios
5-year trend
EBITDA margin
4,5 %
This company
15,8 %
Market median
This company
Market median
72% below market
2021
2025
Equity ratio
45,6 %
This company
38,2 %
Market median
This company
Market median
19% above market
2021
2025
Return on equity
21,2 %
This company
18,4 %
Market median
This company
Market median
15% above market
2021
2025
Net profit margin
3,6 %
This company
8,1 %
Market median
This company
Market median
56% below market
2021
2025
Asset turnover
2,67×
This company
1,12×
Market median
This company
Market median
138% above market
2021
2025
Debt / equity
1,19×
This company
0,62×
Market median
This company
Market median
92% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-07-01 – 2021-06-30
View
PDF
More on Cochlear Norway AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
